Sale by David Meek of 3179 shares of Mirati Ther
MRTXDelisted Stock | USD 31.32 0.15 0.48% |
Slightly above 62% of Mirati Ther's investor base is looking to short. The analysis of current outlook of investing in Mirati Ther suggests that many traders are alarmed regarding Mirati Ther's prospects. Mirati Ther's investing sentiment can be driven by a variety of factors including economic data, Mirati Ther's earnings reports, geopolitical events, and overall market trends.
Mirati |
Filed transaction by Mirati Therapeutics Inc director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Mirati Ther Fundamental Analysis
We analyze Mirati Ther's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mirati Ther using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mirati Ther based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Mirati Ther is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Mirati Ther Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mirati Ther stock to make a market-neutral strategy. Peer analysis of Mirati Ther could also be used in its relative valuation, which is a method of valuing Mirati Ther by comparing valuation metrics with similar companies.
Peers
Mirati Ther Related Equities
HEPA | Hepion Pharmaceuticals | 4.69 | ||||
DAWN | Day One | 1.53 | ||||
KRYS | Krystal Biotech | 0.26 | ||||
AKRO | Akero Therapeutics | 0.22 | ||||
APLS | Apellis Pharmaceuticals | 0.62 | ||||
MDGL | Madrigal Pharmaceuticals | 0.98 | ||||
TERN | Terns Pharmaceuticals | 1.58 | ||||
PTCT | PTC Therapeutics | 2.73 | ||||
VKTX | Viking Therapeutics | 2.88 | ||||
SRPT | Sarepta Therapeutics | 3.33 | ||||
AMLX | Amylyx Pharmaceuticals | 3.48 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |